PriceTargets.com logo

BR Biopharma - BRBI Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$15.21 As of 02/23/2026 02:31 PM ET
▲ +0.16 (1.06%)

This chart shows the closing price for BRBI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BR Biopharma Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BRBI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BRBI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for BR Biopharma in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $15.21.

This chart shows the closing price for BRBI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 polled investment analysts is to sell stock in BR Biopharma.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/30/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/28/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/29/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/27/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/25/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2026
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
2/23/2026

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/13/2026Weiss RatingsInitiated CoverageSell (E-)
(Data available from 2/24/2021 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2025
  • 0 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2026

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.
Read More

Today's Range

Now: $15.21
Low: $15.21
High: $15.21

50 Day Range

MA: N/A

52 Week Range

Now: $15.21
Low: $12.15
High: $67.01

Volume

577 shs

Average Volume

4,830 shs

Market Capitalization

$179.63 million

P/E Ratio

N/A

Dividend Yield

19.43%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of BR Biopharma?

The following equities research analysts have issued reports on BR Biopharma in the last year: Weiss Ratings.
View the latest analyst ratings for BRBI.

What is the current price target for BR Biopharma?

0 Wall Street analysts have set twelve-month price targets for BR Biopharma in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for BR Biopharma in the next year.
View the latest price targets for BRBI.

What is the current consensus analyst rating for BR Biopharma?

BR Biopharma currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe BRBI will underperform the market and that investors should sell shares of BR Biopharma.
View the latest ratings for BRBI.

What other companies compete with BR Biopharma?

Other companies that are similar to BR Biopharma include Astria Therapeutics, Fulgent Genetics, Avanos Medical, Phreesia and Replimune Group. Learn More about companies similar to BR Biopharma.

How do I contact BR Biopharma's investor relations team?

BR Biopharma's physical mailing address is AVENIDA BRIGADEIRO FARIA LIMA 3 732 FLOOR 28 CEP, SAO PAULO, D5 04538, BR. The company's listed phone number is 55-11-3704-1000 and its investor relations email address is [email protected]. The official website for BR Biopharma is www.ri.brpartners.com.br. Learn More about contacing BR Biopharma investor relations.